Tanaka Y - Search Results

1

The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion.

Fung J, Lai CL, Tanaka Y, Mizokami M, Yuen J, Wong DK, Yuen MF. Fung J, et al. Among authors: tanaka y. Am J Gastroenterol. 2009 Aug;104(8):1940-6; quiz 1947. doi: 10.1038/ajg.2009.200. Epub 2009 May 19. Am J Gastroenterol. 2009. PMID: 19455108

2

Lack of association between TTV viral load and aminotransferase levels in patients with hepatitis C or non-B-C.

Kato H, Mizokami M, Orito E, Ohno T, Hayashi K, Nakano T, Kato T, Tanaka Y, Sugauchi F, Mukaide M, Ueda R. Kato H, et al. Among authors: tanaka y. Scand J Infect Dis. 2000;32(3):259-62. doi: 10.1080/00365540050165884. Scand J Infect Dis. 2000. PMID: 10879595

3

Molecular evolutionary analysis of the complete nucleotide sequence of hepatitis B virus (HBV) in a case of HBV infection acquired through a needlestick accident.

Sugauchi F, Mizokami M, Orito E, Ohno T, Hayashi K, Kato T, Tanaka Y, Kato H, Ueda R. Sugauchi F, et al. Among authors: tanaka y. Clin Infect Dis. 2000 Nov;31(5):1195-201. doi: 10.1086/317428. Epub 2000 Nov 7. Clin Infect Dis. 2000. PMID: 11073752

4

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades.

Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ. Tanaka Y, et al. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15584-9. doi: 10.1073/pnas.242608099. Epub 2002 Nov 18. Proc Natl Acad Sci U S A. 2002. PMID: 12438687 Free PMC article.

5

Hepatitis C virus molecular epidemiology in Uzbekistan.

Kurbanov F, Tanaka Y, Sugauchi F, Kato H, Ruzibakiev R, Zalyalieva M, Yunusova Z, Mizokami M. Kurbanov F, et al. Among authors: tanaka y. J Med Virol. 2003 Mar;69(3):367-75. doi: 10.1002/jmv.10298. J Med Virol. 2003. PMID: 12526047

6

[HBV--clinical impact of HBV genotypes].

Tanaka Y, Mizokami M. Tanaka Y, et al. Nihon Rinsho. 2003 Mar;61 Suppl 3:621-6. Nihon Rinsho. 2003. PMID: 12718038 Review. Japanese. No abstract available.

7

Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan.

Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, Hirashima N, Sugauchi F, Ueda R, Mizokami M. Tanaka Y, et al. J Infect Dis. 2003 Jun 1;187(11):1822-5. doi: 10.1086/375248. Epub 2003 May 9. J Infect Dis. 2003. PMID: 12751042

8

Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt.

Saudy N, Sugauchi F, Tanaka Y, Suzuki S, Aal AA, Zaid MA, Agha S, Mizokami M. Saudy N, et al. Among authors: tanaka y. J Med Virol. 2003 Aug;70(4):529-36. doi: 10.1002/jmv.10427. J Med Virol. 2003. PMID: 12794714

9

Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection.

Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, Sakurai M, Fujiwara K, Ohno T, Ueda R, Mizokami M. Suzuki S, et al. Among authors: tanaka y. J Gastroenterol Hepatol. 2003 Oct;18(10):1139-43. doi: 10.1046/j.1440-1746.2003.03161.x. J Gastroenterol Hepatol. 2003. PMID: 12974899

10

Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up.

Suzuki S, Kondo Y, Hirashima N, Kato H, Sugauchi F, Tanaka Y, Orito E, Yang Y, Shen Y, Sakakibara K, Ueda R, Mizokami M. Suzuki S, et al. Among authors: tanaka y. J Gastroenterol Hepatol. 2003 Dec;18(12):1364-72. doi: 10.1046/j.1440-1746.2003.03222.x. J Gastroenterol Hepatol. 2003. PMID: 14675264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,391 results

Search Page

Filters